HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Beier, M. T. Search for Related Content PubMed PubMed Citation Articles by Beier, M. T.

MANJU T. BEIER, PHARM.D., FASCP, is Senior Partner, Geriatric Consultant Resources LLC, and Clinical Associate Professor of Pharmacy, The University of Michigan, 428 Church St., Ann Arbor, MI 48109 (tanja{at}umich.edu).

Purpose. The use of atypical antipsychotics for maximizing clinical efficacy and overall health in patients with neuropsychiatric symptoms of dementia is discussed. Summary. Psychotic and behavioral symptoms are common among older patients with dementia, and an accurate diagnosis can be obscured by complex presentation of symptoms and comorbidities. When initiating pharmacotherapy in this patient population, it is important to consider the increased presence of comorbidities and the additive pharmacologic effects of concomitantly administered drugs. Atypical antipsychotics are among the most well-studied therapeutic classes of psychoactive medications and are frequently utilized for treating psychotic symptoms and agitation in the elderly. These medications have distinct pharmacologic profiles with different liabilities for adverse effects such as sedation, metabolic disturbances, and anticholinergic effects. Recent findings from the Clinical Antipsychotic Trials of Intervention Effectiveness—Alzheimer’s Disease (CATIE-AD) study demonstrate that although these agents have some efficacy, their adverse effects may limit their utility in patients. Conclusion. The adverse effect profile should be an important consideration for clinicians selecting an atypical antipsychotic for use in this population. Index terms: Antipsychotic agents; Dementia; Diagnosis; Drug interactions; Drugs; Geriatrics; Mechanism of action; Toxicity